BRAF and melanoma: Activating mutations in N-RAS and BRAF proto-oncogenes in melanoma increase the glucose uptake by upregulation of glucose transportase-1 (GLUT1) and GLUT3 and enhanced glycolytic rates, as well as modifications of glutamine metabolism [220,221].